MedX Health Corp (MDXHF) Stock
MedX Health Corp is a medical technology company specializing in both diagnostic tools and therapeutic devices. The firm develops, manufactures, and markets advanced solutions for skin screening and light-based therapy, serving customers across Canada, the United States, and international markets.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About MedX Health Corp
MedX Health Corp is a medical technology company specializing in both diagnostic tools and therapeutic devices. The firm develops, manufactures, and markets advanced solutions for skin screening and light-based therapy, serving customers across Canada, the United States, and international markets. Its diagnostic portfolio includes SIAscopy, a cutting-edge medical device technology designed to scan skin for early detection of suspicious moles and lesions. MedX also offers a suite of imaging systems – SIAMETRICS, SIMSYS, and MoleMate – which provide real-time visuals, allowing physicians and dermatologists to rapidly assess various types of moles and lesions. On the therapeutic side, MedX produces phototherapeutic medical devices. These devices employ low-level laser and LED light energy to address pain relief and promote tissue repair, primarily within the rehabilitation sector. To enhance accessibility, MedX operates the DermSecure telemedicine platform. This web-based system enables the remote operation of its SIAscopy technology, facilitating the deployment of its diagnostic tools in a network of third-party locations. Through DermSecure, patient images of moles and lesions, alongside other relevant clinical data, can be securely transmitted to specialist physicians for expert remote assessment. The company was founded in 1999 and its headquarters are situated in Mississauga, Canada.
MedX Health Corp is headquartered in CA.
MedX Health Corp (MDXHF) stock trades at $0.04 with a market capitalization of $14.10M. The stock is valued at a price-to-earnings (P/E) ratio of -3.20, price-to-book of -2.10, price-to-sales of 36.76. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 20.0% below its 52-week high.
On profitability, MedX Health Corp generates a return on equity (ROE) of 62.14% — well above the market average, a sign of a high-quality business, return on capital employed of 50.05%, an operating margin of -738.95%, a net profit margin of 0.00%.
Official website: medxhealth.com